MAP

Microba Life Sciences

Health Care Equipment & Services

Microba Life Sciences is a pioneering company in the health care sector, specializing in advanced microbiome analysis technology. Their innovative approach provides deep insights into gut health, enabling precision diagnostics and personalized treatment plans. With a strong focus on scientific rigor and evidence-based solutions, Microba is positioned as a leader in microbiome research and diagnost...

Microbiome

Health Care

Innovation

Technology

Shorted

short percentage0.00%

reported shorts29.9K

shares on issue608.963M

About

website

microba.com

industry

Health Care Equipment & Services

address

Level 10, 324 Queen Street, BRISBANE, QLD, AUSTRALIA, 4000

Connect

Key Metrics

market cap

$54.81M

eps$-0.03

More Health Care Equipment & Services Stocks

Other shorted stocks in this sector

View all stocks in this industry

Short Position Trends

Track bearish sentiment and short interest over time

Historical Price Data

View stock price movements, volume, and trading patterns

Industry & Focus

Microbiome

Health Care

Innovation

Technology

Diagnostics

Company Overview

AI-generated company summary

Company History

Microba Life Sciences was founded to harness the potential of the human microbiome in improving health outcomes. Over the years, the company has developed cutting-edge technology for microbiome analysis, establishing itself as a leader in the field. Major milestones include the launch of their clinical-grade testing products and the expansion of their research capabilities. Microba continues to innovate, aiming to transform healthcare through microbiome science.

Competitive Advantages

Microba's competitive advantages include their proprietary technology for comprehensive microbiome analysis, which provides deeper insights than traditional methods. Their commitment to scientific rigor ensures that their tests are both safe and effective, setting them apart in the healthcare diagnostics market. Additionally, their focus on personalized healthcare solutions allows them to offer unique value to both practitioners and patients.

Risk Factors

•Regulatory changes in healthcare
•Competition from other biotech firms
•Dependence on scientific research advancements

Recent Developments

Last 6 months

In the past six months, Microba has focused on expanding their product offerings and enhancing their microbiome analysis capabilities. They have also been actively engaging with the scientific community to further validate their technology and its applications in precision healthcare.

Key People

Leadership team at Microba Life Sciences

Unavailable

CEO

Unavailable

CFO

Financial Reports

22 reports available

Q1 FY26 Quarterly Activities Report & Appendix 4C

Quarterly ReportOct 28, 2025via asx_announcements

Details of Q1 FY26 Quarterly Report, Appendix 4C & Webinar

Quarterly ReportOct 23, 2025via asx_announcements

Annual Report to Shareholders

Annual ReportOct 17, 2025via asx_announcements

2025 Annual Report & Appendix 4E

Annual ResultsAug 26, 2025via asx_announcements

Q4 FY25 Quarterly Activities Report & Appendix 4C

Quarterly ReportJul 22, 2025via asx_announcements

Details of Q4 FY25 Quarterly Report, Appendix 4C & Webinar

Quarterly ReportJul 17, 2025via asx_announcements

Q3 FY25 Quarterly Activities Report & Appendix 4C

Quarterly ReportApr 30, 2025via asx_announcements

Details of Q3 FY25 Quarterly Report, Appendix 4C & Webinar

Quarterly ReportApr 28, 2025via asx_announcements

Appendix 4D & FY25 Interim Report

Half Year ResultsFeb 26, 2025via asx_announcements

Q2 FY25 Quarterly Activities Report & Appendix 4C

Quarterly ReportJan 29, 2025via asx_announcements

Showing 10 of 22 reports